|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Novo Nordisk A/S (NVO) to Hire 1000 People in 2 Years in Emerging Markets
10/3/2012 8:23:16 AM
Novo Nordisk A/S (NOVOB), the world’s biggest insulin maker, plans to hire about 1,000 people in the next two years to expand treatment for diabetes in emerging markets such as Vietnam. The Danish company wants to grow in Colombia, Egypt, Ukraine, Malaysia and Indonesia, as well as Vietnam in the years to come, Jesper Hoiland, who heads Novo’s international operations, said in an interview. Novo is adding headcount “rapidly” in these countries, Hoiland said yesterday in Berlin, where he attended the European Association for the Study of Diabetes conference. “Vietnam is going to be a new mini-China.”
|
|
|
|
|
|
|
|
|
|
|